These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2699444)

  • 1. The suppressive effect of cyclophosphamide on low-dose streptozotocin-induced diabetes in mice.
    Yanagawa T; Maruyama T; Takei I; Asaba Y; Takahashi T; Ishii T; Kataoka K; Saruta T; Minoshima S; Shimizu N
    Diabetes Res; 1989 Oct; 12(2):79-83. PubMed ID: 2699444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 2000 May; 191(1):86-92. PubMed ID: 10767724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic effects of dietary administration of Aloe arborescens Miller components on multiple low-dose streptozotocin-induced diabetes in mice: investigation on hypoglycemic action and systemic absorption dynamics of aloe components.
    Beppu H; Shimpo K; Chihara T; Kaneko T; Tamai I; Yamaji S; Ozaki S; Kuzuya H; Sonoda S
    J Ethnopharmacol; 2006 Feb; 103(3):468-77. PubMed ID: 16406411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cyclosporin on autoimmune diabetes induced in mice by streptozotocin: beta cell-toxicity and rebound of insulitis after cessation of treatment.
    Sai P; Maugendre D; Loreal O; Maurel C; Pogu S
    Diabete Metab; 1988; 14(4):455-62. PubMed ID: 3066654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunolocalization of monocyte chemoattractant protein-1 in islets of NOD mice during cyclophosphamide administration.
    Reddy S; Bai Y; Robinson E; Ross J
    Ann N Y Acad Sci; 2006 Oct; 1079():103-8. PubMed ID: 17130538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCG vaccination prevents insulin-dependent diabetes mellitus (IDDM) in NOD mice after disease acceleration with cyclophosphamide.
    Qin HY; Singh B
    J Autoimmun; 1997 Jun; 10(3):271-8. PubMed ID: 9218754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings.
    Cossel L; Schneider E; Kuttler B; Schmidt S; Wohlrab F; Schade J; Bochmann C
    Exp Clin Endocrinol; 1985 Feb; 85(1):7-26. PubMed ID: 3157595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of diabetes in the nonobese diabetic mouse by oral immunological treatments. Comparative efficiency of human insulin and two bacterial antigens, lipopolysacharide from Escherichia coli and glycoprotein extract from Klebsiella pneumoniae.
    Saï P; Rivereau AS
    Diabetes Metab; 1996 Oct; 22(5):341-8. PubMed ID: 8896996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The suppressive effect of anti-asialo GM1 antibody on low-dose streptozotocin-induced diabetes in CD-1 mice.
    Maruyama T; Watanabe K; Yanagawa T; Kasatani T; Kasuga A; Shimada A; Takei I; Suzuki Y; Kataoka K; Saruta T
    Diabetes Res; 1991 Apr; 16(4):171-5. PubMed ID: 1802483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciamexon in the low dose streptozotocin induced diabetes of mice.
    Linn T; Volkmann A; Germann H; Woehrle M; Bretzel RG; Bicker U; Federlin K
    Diabetes Res; 1987 Nov; 6(3):113-7. PubMed ID: 3325216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low frequency low energy pulsing electromagnetic fields on mice injected with cyclophosphamide.
    Cadossi R; Zucchini P; Emilia G; Franceschi C; Cossarizza A; Santantonio M; Mandolini G; Torelli G
    Exp Hematol; 1991 Mar; 19(3):196-201. PubMed ID: 1995311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L3T4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice.
    Kantwerk G; Cobbold S; Waldmann H; Kolb H
    Clin Exp Immunol; 1987 Dec; 70(3):585-92. PubMed ID: 2963718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of infection by lactic dehydrogenase virus on expression of intercellular adhesion molecule-1 on vascular endothelial cells of pancreatic islets in streptozotocin-induced insulitis of CD-1 mice.
    Hayashi T; Hashimoto S; Kawashima A
    Int J Exp Pathol; 1994 Jun; 75(3):211-7. PubMed ID: 7916200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway.
    Ablamunits V; Quintana F; Reshef T; Elias D; Cohen IR
    J Autoimmun; 1999 Dec; 13(4):383-92. PubMed ID: 10585754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
    Liu F; Yu M; Zhu Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of action mechanism of lymphotoxin in prevention of cyclophosphamide-induced diabetes in NOD mice.
    Takahashi K; Satoh J; Sagara M; Zhu XP; Muto G; Muto Y; Fukuzawa M; Nishimura S; Miyaguchi S; Toyata T
    J Autoimmun; 1995 Jun; 8(3):335-46. PubMed ID: 7575995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis.
    Matsumoto M; Yagi H; Kunimoto K; Kawaguchi J; Makino S; Harada M
    Cell Immunol; 1993 Apr; 148(1):189-97. PubMed ID: 8098666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin autoantibodies in non-obese diabetic (NOD) mice and streptozotocin-induced diabetic mice.
    Maruyama T; Takei I; Yanagawa T; Takahashi T; Asaba Y; Kataoka K; Ishii T
    Diabetes Res; 1988 Feb; 7(2):93-6. PubMed ID: 3293880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct.
    Nicoletti F; Di Marco R; Papaccio G; Conget I; Gomis R; Bernardini R; Sims JE; Shoenfeld Y; Bendtzen K
    Eur J Immunol; 2003 Aug; 33(8):2278-86. PubMed ID: 12884303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin therapy does not diminish beta-cell damage in the neonatal streptozotocin-injected rat.
    Wolffenbuttel BH; Vreeburg J
    Diabetes Res; 1988 Oct; 9(2):77-9. PubMed ID: 3073032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.